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ABSTRACT 
The aim of this work was to study the neurodegenerative effects of the 
organophosphate (OP) pesticides chlorpyrifos (CPF) and chlorpyrifos-methyl (CHM) 
on cultured mouse N2a neuroblastoma cells. CPF or CHM, at a subcytotoxic 
concentration of 3μM, were added to the cells either at the time of the induction of 
cell differentiation (co-differentiation) or 16 h after the induction of differentiation 
(post-differentiation). CPF and CHM were similar in inhibiting significantly the 
outgrowth of axon-like processes from N2a cells after only 4 h exposure under both 
co- and post-differentiation exposure conditions. Densitometric scanning of Western 
blots of extracts of cells treated with CPF or CHM for 4 h revealed significantly 
decreased cross-reactivity with a monoclonal antibody recognizing the protein GAP-
43 under post- but not under co-differentiation exposure conditions. Exposure to CPF 
or CHM for 4 h under post-differentiation conditions also resulted in reduced 
fluorescence of N2a cell body staining with anti-GAP-43. Cross-reactivity of Western 
blots with a monoclonal antibody recognizing α-tubulin was not significantly affected 
by OP treatment. These data indicate that a disturbance in GAP-43 may be important 
in the retraction of axons in pre-differentiated N2a cells and support the notion that 
the mechanisms involved in CPF- and CHM-induced inhibition of axonal outgrowth 
may be different under co- and post-differentiation exposure conditions.  
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INTRODUCTION 
Chlorpyrifos (CPF) and chlorpyrifos-methyl (CHM) are broad-spectrum 
organophosphate (OP) pesticides. CPF is widely used in agriculture, veterinary 
medicine and in the household. This compound has been shown to have 
developmental neurotoxicity (Campbell et al. 1997; Crumpton et al. 2000). In 
addition, under certain conditions it is capable of inducing a characteristic delayed-
onset neuropathy known as organophosphate-induced delayed neuropathy (OPIDN) 
(Richardson 1995).  
In order to study the molecular basis of CPF-induced neurotoxicity in more detail, our 
own work has focussed on the effects of subcytotoxic concentrations of CPF on 
differentiating mouse N2a neuroblastoma cells(Sachana et al. 2001). In this cellular 
system, it is possible to determine the effects of CPF on the outgrowth and retraction 
of axons by adding the OP at the point of induction of cell differentiation (co-
differentiation) or following 16 h of cell differentiation (post-differentiation), 
respectively. Axon numbers were significantly lower than controls following 4h 
exposure to 3 μM CPF under both co-differentiation and post-differentiation 
conditions, indicating that this compound not only inhibited axon outgrowth but also 
caused retraction of pre-formed axons in this cellular system (Sachana et al. 2001).  
Impairment of axonal outgrowth in cell culture models by OPs has been associated 
with a number of mechanisms including the inhibition of the enzyme neuropathy 
target esterase (NTE) (Li and Casida 1998; Sachana et al. 2001) as well as the 
disruption of cytoskeletal proteins (Flaskos et al. 1998; Schmuck and Ahr 1997). In 
our work, CPF was found to inhibit neuropathy target esterase (NTE) activity in N2a 
cells after 4 h under co-differentiation conditions (Sachana et al. 2001), in agreement 
with the developmental neurotoxicity reported for this compound (Campbell et al. 
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1997; Crumpton et al. 2000). In contrast, 4 h exposure of pre-differentiated N2a cells 
to CPF had no effect on NTE activity (Sachana et al. 2001). Similarly, exposure of 
N2a cells to CPF for 4 h caused an increase in the levels of the heat-shock protein 
HSP-70 under co- but not under post-differentiation conditions (Sachana et al. 2001). 
These data indicate that the mechanism(s) associated with the CPF-induced retraction 
of axons in N2a cells are different from those involved in the inhibition of axon 
outgrowth by the same compound.   
Of further interest to the current work is the toxicity of CHM, the dimethyl ester of 
CPF, which has been mainly used in the control of insect pests on certain stored 
grains. There is a paucity of available data concerning the neurotoxic properties of 
this OP, as indicated in a recent review published by the U.S. Environmental 
Protection Agency (EPA 2000).  
The aim of this study is to study the ability of CPF and CHM to inhibit axon 
outgrowth and to cause axon retraction in differentiating N2a cells. At a molecular 
level, special emphasis has been placed on the effects of these OPs on the levels and 
the intracellular distribution of the proteins α-tubulin and GAP-43, both of which are 
important in axonal outgrowth and/or stabilization (Meiri et al. 1986, 1998; Keith 
1990; Knoops and Octave 1997). This would help to define further the different 
mechanisms underlying the ability of certain OPs to cause axon retraction and to 
inhibit axon outgrowth.  
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MATERIALS AND METHODS  
Materials 
The mouse N2a neuroblastoma cell line was purchased from ICN (Thane, UK). All 
sterile plasticware was obtained from Scientific Laboratory Supplies (Nottingham, 
UK). All cell culture media components, mouse anti-α-tubulin (B512) and mouse 
anti-GAP-43 (GAP-7B10) monoclonal antibodies were acquired from Sigma Aldrich 
Chemical Co. (Poole, UK). Rabbit anti-mouse horseradish peroxidase (HRP) and 
fluorescein isothiocyanate (FITC) conjugates were bought from Dako Ltd. 
(Cambridge, U.K.). The OP pesticides, chlorpyrifos and chlorpyrifos-methyl (purity 
99%) were obtained from Riedel de Haen (Seelze, Germany). All other chemicals 
were purchased from Sigma Aldrich Chemical Co (Poole, UK). 
Cell Maintenance and Differentiation  
N2a cells were maintained as a monolayer in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with serum, glutamine and antibiotics, as described 
previously (Flaskos et al. 1998; Fowler et al. 2001). Cells were plated out in growth 
medium at a density of 50,000 cells/ml and allowed to grow for 24 h. In co-
differentiation (CD) experiments, cell differentiation was induced by the addition of 
0.3 mM dibutyryl-cAMP (dbcAMP) in serum-free medium with or without 3 μM CPF 
or CHM, previously dissolved in ethanol. This was followed by incubation for 4 h at 
37°C in a humidified atmosphere of 95% air and 5% CO2. The final ethanol 
concentration in the medium of OP-treated and untreated control cells was 0.5% v/v. 
In the case of post-differentiation (PD) experiments, cells were allowed to 
differentiate under the influence of dbcAMP in serum-free medium for 16 h prior to 
exposure to CPF or CHM for 4 h.  
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Determination of Cell Viability  
The effects of 3 μM CPF and CHM on cell viability were determined by the reduction 
of 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) to formazan 
crystals (Mosmann 1983). This spectrophotometric assay was conducted on N2a cells 
cultured in 24-well plates and treated with the OPs for 4 h under both differentiation 
conditions described above. 
Outgrowth of Axon-like Processes 
N2a cells seeded in 24-well plates and treated with CPF, CHM or ethanol were fixed 
with 90% (v/v) methanol in phosphate buffered saline (PBS) at –20oC for 20 min. 
They were subsequently stained with Coomassie brilliant blue R-250 (1.25% w/v in 
40% v/v methanol and 20% v/v glacial acetic acid in distilled water) for 1 min at 
room temperature. Stained cells were washed with distilled water and left to air dry 
for 24 h. From each well, 5 randomly chosen fields were viewed with the aid of an 
inverted light microscope at 200× magnification. The total number of cells and axon-
like processes in each field were counted and the number of axons per 100 cells was 
determined. An axon-like process was considered to be an extension with a length 
greater than two cell body diameters (Keilbaugh et al. 1991; Flaskos et al. 1998; 
Fowler et al. 2001). 
Gel Electrophoresis and Western Blotting  
For immunoblotting analysis the N2a cells were seeded in a volume of 10 ml of 
growth medium in culture flasks at a density of 50,000 cells/ml and induced to 
differentiate, as described above. Cultures differentiated in the presence or absence of 
CPF or CHM were solubilised in 1ml of electrophoresis sample buffer and separated 
by SDS-PAGE (Laemmli 1970). Equal amounts (approximately 20 μg) of cell protein 
were loaded and the protein was estimated using the method of Lowry et al (1951), 
 6
with minor modifications. Following electrophoresis, the separated proteins were 
blotted onto nitrocellulose membrane filters (Towbin et al. 1979). The resultant 
Western blots were checked for efficient transfer of proteins and the correct sample 
loading, by staining with 0.05% copper pthalocyanine in 12mM HCl. They were then 
destained with 12mM NaOH, prior to blocking with 3% BSA in Tris buffered saline 
(TBS: 10 mM Tris, 140 mM NaCl), pH 7.4. The blots were then probed with 
monoclonal antibodies that recognize α-tubulin (clone B512, diluted 1:2000 in 3% 
BSA/TBS) and GAP-43 (clone GAP-7B10, diluted 1:1000 in 3% BSA/TBS) followed 
by incubation with HRP-conjugated rabbit anti-mouse IgG. Antibody reactivity was 
revealed by enhanced chemiluminescence (ECL, Amersham, UK). 
Quantification of Antibody Reactivity on Western Blots 
Densitometric scanning of Western blots was performed by using the Quantiscan 
image analysis system (Version 1.5; Biosoft) interfaced to a high-resolution CCD 
video camera. Blots were digitized and the protein levels were quantified by directly 
relating antibody reactivity to specific protein level. Using the Quantiscan software 
program, individual lanes were superimposed over the region of interest, from which a 
peak profile could be constructed. All peak areas were expressed as a percentage of 
the corresponding control value, using the same threshold for background subtraction. 
Indirect immunofluorescence  
The cells were seeded on to glass coverslips and induced to differentiate for 16h, prior 
to treatment for 4 h with 3 μM CPF or CHM. They were then fixed at  -20 °C for 10 
min in 90% methanol, blocked by incubation in 3 % BSA in TBS followed by 
incubation overnight at 4 °C with the primary antibody B512 (diluted 1:200) or GAP-
7B10 (diluted 1:50 in 3% BSA/TBS). After washing in TBS to remove unbound 
primary antibody, cells were incubated with the secondary antibody, FITC-conjugated 
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rabbit anti-mouse IgG (diluted 1:50 in 3% BSA/TBS). Cells were then visualized with 
a Leica confocal laser scanning microscope in order to determine whether exposure to 
OPs induced changes in the intracellular distribution of tubulin or GAP-43. 
Statistical Analysis  
Statistical analyses of the data were performed using Mann-Whitney U-test for non-
parametric distribution or using the Student’s t-test, as appropriate, using 95% confidence 
limits. Data were expressed as mean ± S.E.M. values.  
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RESULTS 
In order to compare the ability of CHM to cause neurodegenerative effects to that of 
CPF, the effects of these compounds on the outgrowth of axon-like processes in 
differentiating N2a cells were studied in parallel. Both CHM and CPF were used at a 
concentration of 3 μM, which was shown to have no effect on the viability of N2a 
cells, under both differentiation conditions (Table 1). At this concentration, both OPs 
were found to cause a significant reduction in the outgrowth of axon-like processes by 
N2a cells compared to the controls within 4 h. These effects were noted either when 
the OPs were added at the time of induction (CD) or 16 h after the induction of cell 
differentiation (PD) (Table 2).  
Western blotting analysis was carried out to investigate the molecular mechanism(s) 
involved in the retraction of axon-like processes by the two OPs. For this purpose, 
blots were probed with antibodies recognizing α-tubulin and the axon growth-
associated protein GAP-43, both of which are proteins known to be associated with 
axon outgrowth and/or stabilization (Meiri et al. 1986, 1998; Keith 1990; Knoops and 
Octave 1997). Immunoblot analysis revealed a decrease in reactivity of cell extracts 
with GAP-7B10 antibody, following 4-h post-differentiation exposure to CHM or 
CPF (Figure 1d, left panel). Indeed, densitometric analysis of cells exposed to 3 µM 
CHM or CPF, under the above experimental conditions, showed that GAP-7B10 
reactivity was significantly reduced (p < 0.05) by 53.9% ± 4.8 and 34.3% ± 5.4, 
respectively, compared with controls (Figure 1d, right panel). However, a slight but 
not significant increase was observed in reactivity with GAP-7B10 under co-
differentiation conditions (Figure 1c). Exposure to both compounds had no effect on 
reactivity with B512 anti-tubulin antibody under co-differentiation conditions (Figure 
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1a) and caused slight but not significant reductions under post-differentiation 
conditions (Figure 1b).  
Exposure to 3 μM CHM or CPF for 4 h post-differentiation resulted in weaker 
fluorescence of GAP-43 staining over the nucleus of N2a cells compared to the 
controls (Figure 2d, e, f). In control N2a cells, the protein GAP-43 recognized by 
GAP-7B10 staining was evident in the cell body and partially obscured the nucleus 
(Figure 2d). No major changes in the level or distribution of B512 staining in OP-
treated cells compared to controls were detected under the same experimental 
conditions (Figure 2a, b, c). 
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DISCUSSION 
The data presented in this work demonstrate that both CPF and CHM are capable of 
inhibiting the formation and maintenance of axons in cultured mouse N2a 
neuroblastoma cells after only 4 h exposure.  
 
Effects of CPF and CHM on axon outgrowth 
 
The inhibitory effects of CHM on axon outgrowth, studied for the first time in the 
present work, are similar to those of CPF as well as to those of other neuropathic OPs 
tested previously on the same cell line (Fowler et al. 2001, Sachana et al. 2003). 
Altered expression and distribution of GAP-43 and α-tubulin have been previously 
related to the neurodegenerative properties of various chemical compounds (Di Luca 
et al. 1994; Hargreaves 1997). However, the data obtained in the present work 
indicate that, although the test OPs both inhibited the formation of axons in N2a cells, 
α-tubulin and GAP-43 levels were not significantly affected. In previous work, it was 
also found that CPF had no effect on neurofilament heavy chain levels under the same 
exposure conditions but caused a significant increase in the levels of HSP-70 
(Sachana et al. 2001).  
 
 
Effects of CPF and CHM on axon maintenance 
 
Morphological assessment of pre-differentiated cells indicated that exposure to both 
compounds caused retraction of pre-formed axons. As in the case of axon outgrowth 
experiments, analysis of Western blots probed with monoclonal antibody B512 
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indicated that there was no significant change in the levels of total α-tubulin 
compared to untreated controls. By contrast, analysis of blots probed with monoclonal 
antibody GAP-7B10 suggested that exposure to both OPs caused a significant 
reduction in the levels of GAP-43 compared to controls.  
 
This may reflect an OP-induced reduction in synthesis or increased turnover of GAP-
43 under post differentiation exposure conditions. The observed retraction of axons 
after exposure of the pre-differentiated N2a cells to CPF and CHM is consistent with 
the fact that GAP-43 levels increase during axon outgrowth and are important in the 
maintenance of axons (Skene 1989). The reduced staining intensity noted in the cell 
bodies of the OP-treated pre-differentiated N2a cells probed with GAP-7B10 is 
consistent with the decrease in the levels of GAP-43 detected on Western blots of 
extracts from cells exposed to CPF and CHM under the same conditions. This further 
suggests that exposure to these OP compounds could lead to a disturbance in GAP-43 
synthesis or turnover and, possibly, to reduced transport of this protein from the cell 
body to the axon and dendrites. 
 
Proposed mechanism of toxicity 
The present study provides the first evidence for an early biochemical change that is 
linked to the CPF- and CHM-induced retraction of axons in pre-differentiated N2a 
cells. These findings add further support to our previous data indicating that the 
mechanisms involved in the CPF-induced retraction of axons in N2a cells may be 
different under co- and post-differentiation conditions (Sachana et al. 2001). For 
example, in previous studies showing the induction of axon retraction by CPF in pre-
differentiated cells, NTE activity and levels of HSP-70 and the cytoskeletal protein 
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neurofilament heavy chain (NF-H) were unaffected, whereas they were reduced or 
increased respectively under co-differentiation exposure conditions (Sachana et al. 
2001).  
The observed retraction of axons after exposure of the pre-differentiated N2a cells to 
CPF and CHM is consistent with the fact that GAP-43 levels increase during axon 
outgrowth and are important in the maintenance of axons (Skene 1989). The reduced 
levels of GAP-43 following post-differentiation exposure to the two OPs could be due 
to decreased synthesis or increased turnover of the protein. This perturbation in GAP-
43 levels may be mechanistically important as it could play a role in the 
morphological effects of CPF and CHM on the maintenance of axon-like processes. 
For example, consistent with the proposed role of GAP-43 as a cytoskeleton-
membrane linker that plays an important role in axon development and stability 
(Skene 1989; Meiri et al. 1986, 1998), reduced levels of GAP-43 could destabilise the 
axon by reducing cytoskeleton-membrane interactions. 
 
By contrast, the blot and staining pattern of α-tubulin in N2a cells were not found to 
be significantly affected under any conditions by CPF and CHM, suggesting that 
microtubule disruption was not responsible for the observed inhibition of axon 
outgrowth and the induction of axon retraction. This is consistent with the finding that 
tubulin synthesis shows small or no specific increase during axon outgrowth (Joshi 
and Baas 1993). Altered α-tubulin mRNA expression has been reported in the central 
nervous system of hens and rats following exposure to the OP compounds sarin and 
diisopropyl phosphorofluoridate (DFP) (Damodaran et al. 2001; 2002). The latter OP 
has very potent OPIDN-inducing properties and it has been suggested that the 
observed disturbance in α-tubulin may be associated with the development of OPIDN 
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or could, alternatively, represent the consequence of important changes occurring 
during the progression of OPIDN (Damodaran et al. 2001). 
 
The investigation of the neurotoxic properties of CHM undertaken in this study 
demonstrates that this OP not only exerts effects comparable to those of CPF on axon 
outgrowth but also that this OP is similar to CPF in terms of its effects on the levels 
and distribution of GAP-43 and α-tubulin under all conditions studied. CHM and CPF 
have been recently shown to have similar relative enzyme inhibitory potencies for 
acetylcholinesterase versus NTE and similar abilities to cause OPIDN (Kropp and 
Richardson 2003). Our present data suggest that, in serum withdrawal-mediated 
axonal outgrowth in N2a cells in vitro, there exists a similar pattern of effects for the 
two OPs at a molecular level.  
 14
REFERENCES 
Abou-Donia, M. B., Lapadula, D. M., and Suwita, E. 1988. Cytoskeletal proteins as 
targets for organophosphorus compound and aliphatic hexacarbon-induced neuro 
toxicity. Toxicology 43: 469-477. 
Campbell, C. G., Seidler, F. J., and Slotkin, T. A. 1997. Chlorpyrifos interferes with 
cell development in rat brain regions. Brain. Res. Bull. 43: 179-183.  
Crumpton, T. L., Seidler, F. J., and Slotkin, T. A. 2000. Developmental neurotoxicity 
of chlorpyrifos in vivo and in vitro: effects on nuclear transcription factors involved in 
cell replication and differentiation. Brain Res. 857: 87-98. 
Damodaran, T. V., Abdel-Rahman, A., and Abou-Donia, M. B. 2001. Altered time 
course of mRNA expression of alpha tubulin in the central nervous system of hens 
treated with diisopropyl phosphorofluoridate (DFP). Neurochem. Res. 26(1): 43-50. 
Damodaran, T. V., Mecklai, A. A., and Abou-Donia, M. B. 2002. Sarin causes altered 
time course of mRNA expression of alpha tubulin in the central nervous system of 
rats. Neurochem. Res. 27: 177-181. 
Di Luca, M., Caputi, A., and Cattabeni, F. 1994. Synaptic protein phosphorylation 
changes in animals exposed to neurotoxicants during development. Neurotoxicology 
15: 525–532. 
EPA 2000. Office of Pesticide Programs, Overview on the chlorpyrifos methyl 
revised risk assessment; http://www.epa.gov/pesticide/op/chlorpyrifos 
methyl/overview. 
Flaskos, J., McLean, W. G., Fowler, M. J., and Hargreaves, A. J. 1998. Tricresyl 
phosphate inhibits the formation of axon-like processes and disrupts neurofilaments in 
cultured mouse N2a and rat PC12 cells. Neurosci. Lett. 242: 101-104.  
 15
Fowler, M. J., Flaskos, J., McLean, G. W., and Hargreaves, A. J. 2001. Effects of 
neuropathic and non-neuropathic isomers of tricresyl phosphate and their microsomal 
activation on the production of axon-like processes by differentiating mouse N2a 
neuroblastoma cells. J. Neurochem. 76: 671 - 678. 
Hargreaves, A. J. 1997. The cytoskeleton as target in cell toxicity. Advanc. Molec. 
Cell Biol. 20: 119-144. 
Joshi, H. C., and Baas, P. W. 1993. A new perspective on microtubules and axon 
outgrowth. J. Cell Biol. 121: 1191-1196. 
Keilbaugh, S. A., Prusoff, W. H., and Simpson M. V. 1991. The PC12 cell as a model 
for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-I 
dideoxynucleoside analogs. Biochem. Pharmacol. 42: R5–R8. 
Keith, C.H. 1990. Neurite elongation is blocked if microtubule assembly is inhibited 
in PC12 cells. Cell Motil. Cytoskel. 17: 95-105. 
Knoops, B. and Octave, J.N. 1997. Alpha-1 tubulin mRNA level is increased during 
neurite outgrowth of NG108-15 cells but not during neurite outgrowth inhibition by 
CNS myelin. NeuroReport  8: 795-798. 
Kropp, T., and Richardson, R. 2003. Relative inhibitory potencies of chlorpyrifos 
oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus 
neuropathy target esterase. J. Toxicol. Environ. Health 66: 1145-1157. 
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head 
of bacteriophage T4. Nature 227: 680-685. 
Li, W., and Casida, J. E. 1998. Organophosphorus neuropathy target esterase 
inhibitors selectively block outgrowth of neurite-like and cell processes in cultured 
cells. Toxicol. Lett. 98: 139-146. 
 16
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. 1951. Protein 
measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–275. 
Meiri, K.F., Pfenninger, K.H. and Willard, M.B. 1986. Growth-associated protein, 
GAP-43, a polypeptide that is induced when neurons extend axons, is a component of 
growth cones and corresponds to pp46,  a major polypeptide of a subcellular fraction 
enriched in growth cones. Proc. Natl. Acad. Sci. USA 83: 3537-3541. 
Meiri, K.F., Saffell, J.L., Walsh, F.S. and Doherty, P. 1998. Neurite outgrowth 
stimulated by neural cell adhesion molecules requires growth-associated protein-43 
(GAP-43) function and is associated with GAP-43 phosphorylation in growth cones. 
J. Neurosci. 18: 10429-10437. 
Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: 
application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63. 
Richardson, R. J. 1995. Assessment of the neurotoxic potential of chlorpyrifos relative 
to other organophosphorus compounds: a critical review of the literature. J. Toxicol. 
Environ. Health 44: 135-165. 
Sachana, M., Flaskos, J., Alexaki, E., Glynn, P., and Hargreaves, A. J. 2001. The 
toxicity of chlorpyrifos towards differentiating mouse N2a neuroblastoma cells. 
Toxicol. In Vitro 15: 369-372. 
Sachana, M., Flaskos, J., Alexaki, E., and Hargreaves, A. J. 2003. Inhibition of neurite 
outgrowth in N2a cells by leptophos and carbaryl: effects on neurofilament heavy 
chain, GAP-43, HSP-70. Toxicol. In Vitro 17:115-120. 
Schmuck, G., and Ahr, H. J. 1997. In vitro method for screening organophosphate-
induced delayed polyneuropathy. Toxicol. In Vitro 11: 263-270. 
Skene, J. H. P. 1989. Axonal growth-associated proteins. Annu. Rev. Neurosci. 12: 
127-156. 
 17
Towbin, H., Staehelin, T., and Gordon, J. 1979. Electrophoretic transfer of proteins 
from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 
Proc. Natl. Acad. Sci. USA 76: 4350-4354. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18
Fig. 1: Western blotting analysis of extracts from N2a cells exposed to 
subcytotoxic levels of CHM and CPF. 
Left panel: N2a cells were incubated in presence or absence of CHM or CPF under 
co- or post-differentiation conditions, before solubilisation of the cell monolayer in 
electrophoresis sample buffer. Equal cell protein amounts were separated by SDS-
PAGE and then transferred onto nitrocellulose membrane filters. Blots were then 
probed with antibodies that recognize α-tubulin (clone B512) (a, b) and GAP-43 
(clone GAP-7B10) (c, d). Right panel: Digital images of probed blots were analysed 
densitometrically using Quantiscan image analysis software. Data are mean ± S.E.M. 
of three separate experiments. The results are expressed as a percentage of the 
corresponding control (defined as the 100% value). 
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Fig. 2: Immunostaining of N2a cells exposed to subcytotoxic levels of CHM and 
CPF. N2a cells were incubated in the presence or absence of CHM or CPF under 
post-differentiation conditions, before they were fixed and processed for 
immunofluorescence using an antibody that recognizes α-tubulin (clone B512) and 
GAP-43 (clone GAP-7B10). N2a cells were viewed with a Leica confocal laser 
scanning microscope. Shown are control cells (a, d), CHM-treated cells (b, e) and 
CPF-treated cells (c, f) stained with B512 (a, b, c) and GAP-7B10 (d, e, f). White 
scale bar = 30 μm. 
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Differentiation 
conditions and 
exposure time (h) 
 
 
MTT reduction (A 570)  
  
Control 
 
 
Chlorpyrifos - methyl 
 
Chlorpyrifos 
 
 
4 h CD 
 
 
 
0.41 ± 0.02 
 
 
0.43 ± 0.01 
 
 
0.47 ± 0.03 
 
 
4 h PD 
 
 
 
0.56 ± 0.05 
 
 
0.70 ± 0.01 
 
 
0.74 ± 0.04 
 
 
 
 
TABLE 1: Effects of CHM and CPF on MTT reduction in N2a cells. 
 
N2a cells were induced to differentiate in the presence or absence of 3 μM CHM or 
CPF (co-differentiation, CD) or they were treated with CHM or CPF after 16 h of 
differentiation (post-differentiation, PD), and the level of MTT reduction was 
determined. Results are expressed as mean absorbance ± S.E.M. (n = 8 culture wells, 
from cells grown on at least two separate occasions). 
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